EUVIMEDEUVIMED entdecken
Crossref

Selective Cell Size MRI for the Diagnosis and Grading of Clinically Significant Prostate Cancer: A Feasibility Study

Hao Cheng, Jie Lu, Ming Liu iD, Wei Zhang, Jinxia Zhu, Min Chen, Dan Wu iD, Chunmei Li iD

NMR in Biomedicine · 2026-04 · 39 (4)

DOI: 10.1002/nbm.70267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 13.03.2026. Verfasst von Hao Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beij…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging, Cell Size. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding, Key Project of Hangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinically significant prostate cancer (csPCa) and benign prostate tissue are composed of distinct cell populations. Selective size imaging using filters via diffusion times (SSIFT) MRI, a novel technique generating cell size–weighted maps sensitive to specific cell sizes (e.g., cancer cells), has an unclear clinical value in prostate cancer. This study aimed to evaluate whether SSIFT MRI can serve as a novel imaging biomarker for prostate cancer, specifically for discriminating csPCa from clinically insignificant disease (CIS). A total of 152 men (89 with csPCa and 63 with CIS) suspected of csPCa were prospectively enrolled, with 229 lesions (93 with csPCa and 136 with CIS) delineated. SSIFT MRI data were acquired using pulsed and oscillating gradient diffusion sequences to generate incremental AUC (iAUC). We evaluated the performance of iAUC, the apparent diffusion coefficient (ADC), and prostate‐specific antigen density (PSAD) in discriminating csPCa from CIS and assessing Gleason grade group (GGG). Additionally, correlations between iAUC and pathologic parameters (nuclei fraction, diameter, and cellularity) were analyzed in patients with whole histopathologic slides. Higher GGG was associated with increased iAUC values (GGGs 1–5: 3.34% ± 1.28%, 5.31% ± 2.33%, 6.18% ± 2.71%, 6.36% ± 2.23%, and 6.23% ± 1.15%, respectively). For distinguishing csPCa from CIS, iAUC exhibited the highest diagnostic performance, with AUCs of 0.91 (peripheral zone), 0.86 (transitional zone), and 0.89 (whole prostate). In per‐patient analysis, the combined model incorporating iAUC, ADC_50ms, and PSAD achieved the highest diagnostic accuracy (86%, 131/152) and AUC (0.93; 95% CI: 0.88–0.97). Histopathological analysis revealed a mean prostate cancer nuclei diameter of 10.98 ± 1.81 μm, within the SSIFT filter range (10–20 μm). These findings suggest that SSIFT MRI shows promise as a novel imaging biomarker for prostate cancer, enabling noninvasive identification of csPCa and optimizing clinical decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance ImagingCell SizeHumansMaleFeasibility StudiesNeoplasm GradingMiddle AgedAgedDiffusion Magnetic Resonance ImagingClinical RelevanceROC Curve

Stichwörter der Autor:innen

diffusion weighted imagingmagnetic resonance imagingprostate cancerquantitative analysis

Autor:innen und Institutionen

  • Department of Radiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P. R. China.
  • Graduate School of Peking Union Medical College, Beijing, P. R. China.
  • Key Laboratory for Biomedical Engineering of the Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, P. R. China.
  • Department of Urology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P. R. China.
  • Department of Pathology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P. R. China.
  • MR Research Collaboration, Siemens Healthineers, Beijing, P. R. China.

ORCID-Profile: Ming Liu, Dan Wu, Chunmei Li

Förderung

  • National Natural Science Foundation of China
  • National High Level Hospital Clinical Research Funding
  • Key Project of Hangzhou

Zitieren

APA

Cheng, H., Lu, J., Liu, M., Zhang, W., Zhu, J., Chen, M., Wu, D., & Li, C. (2026). Selective Cell Size MRI for the Diagnosis and Grading of Clinically Significant Prostate Cancer: A Feasibility Study. NMR in Biomedicine, 39(4). https://doi.org/10.1002/nbm.70267

Vancouver

Cheng H, Lu J, Liu M, Zhang W, Zhu J, Chen M, et al. Selective Cell Size MRI for the Diagnosis and Grading of Clinically Significant Prostate Cancer: A Feasibility Study. NMR in Biomedicine. 2026;39(4). doi:10.1002/nbm.70267

BibTeX
@article{Cheng2026,
  author = {Cheng, Hao and Lu, Jie and Liu, Ming and Zhang, Wei and Zhu, Jinxia and Chen, Min and Wu, Dan and Li, Chunmei},
  title = {Selective Cell Size MRI for the Diagnosis and Grading of Clinically Significant Prostate Cancer: A Feasibility Study},
  journal = {NMR in Biomedicine},
  year = {2026},
  volume = {39},
  number = {4},
  doi = {10.1002/nbm.70267}
}
Kostenlos starten →